Literature DB >> 12481941

Thymosin beta-10 protein synthesis suppression reduces the growth of human thyroid carcinoma cells in semisolid medium.

Giovanni Santelli1, Paola Cannada Bartoli, Ada Giuliano, Antonio Porcellini, Alba Mineo, Maria Vittoria Barone, Immacolata Busiello, Francesco Trapasso, Daniela Califano, Alfredo Fusco.   

Abstract

Beta-thymosins are structurally related, highly conserved acidic polypeptides, originally isolated from calf thymus. We have recently shown that the TB10 gene is overexpressed in human thyroid carcinoma cell lines and tissues, particularly in undifferentiated thyroid carcinomas, but expressed at an undetectable level in normal thyroid cells. The precise role of thymosin beta-10 (TB10) activity in maintaining the malignant phenotype of thyroid cell lines is unknown. To investigate TB10 function and relevance in a model system we used an antisense methodology to suppress TB10 protein synthesis in two human thyroid carcinoma cell lines (NPA and ARO). The growth in soft agar of NPA and ARO cells carrying a TB10 construct in an antisense orientation was significantly reduced. Conversely, anchorage-dependent growth was unchanged in NPA and ARO cells carrying the TB10 construct in a sense orientation or carrying the backbone vector. TB10 expression also affected actin organization. In fact, stress fibers were long and thick in ARO cells in which TB10 expression was suppressed by the antisense construct. Conversely, they were scarce and short in the vector-transfected ARO cells. These data suggest that TB10 plays a critical role in the regulation of anchorage-independent growth and assembly of actin filaments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481941     DOI: 10.1089/105072502760339325

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  5 in total

1.  Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas.

Authors:  Liliána Z Fehér; Gábor Pocsay; László Krenács; Agnes Zvara; Enikő Bagdi; Réka Pocsay; Géza Lukács; Ferenc Győry; Andrea Gazdag; Erzsébet Tarkó; László G Puskás
Journal:  Pathol Oncol Res       Date:  2011-12-11       Impact factor: 3.201

2.  Thymosin beta-10 is aberrantly expressed in pancreatic cancer and induces JNK activation.

Authors:  Min Li; Yuqing Zhang; Qihui Zhai; Louis W Feurino; William E Fisher; Changyi Chen; Qizhi Yao
Journal:  Cancer Invest       Date:  2009-03       Impact factor: 2.176

3.  Thymosin β10 expression driven by the human TERT promoter induces ovarian cancer-specific apoptosis through ROS production.

Authors:  Young-Chae Kim; Byoung-Gie Kim; Je-Ho Lee
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

4.  Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma.

Authors:  W Theunissen; D Fanni; S Nemolato; E Di Felice; T Cabras; C Gerosa; P Van Eyken; I Messana; M Castagnola; G Faa
Journal:  Eur J Histochem       Date:  2014-03-11       Impact factor: 3.188

5.  Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties.

Authors:  Galina D Kutuzova; Hector F Deluca
Journal:  Arch Biochem Biophys       Date:  2004-12-15       Impact factor: 4.013

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.